Table Of Contents

1. Market Context & Strategic Relevance

 1.1 Opening Context (Why the market matters)

 1.1.1 Why This Market Is Gaining Strategic Attention

     1.1.2 Business Decisions This Report Supports

 1.2 Scope

2. Executive Summary

 2.1 Market Snapshot

 2.2 Market Absolute $ Opportunity Assessment & Y-o-Y Analysis, 2022–2035

 2.3 Market Size & Forecast, By Segmentation, 2022–2035

  2.3.1 Market Size by Product & Service

  2.3.2 Market Size by Application

  2.3.3 Market Size by End Use

 2.4 Market Share & Bps Analysis by Region, 2025

 2.5 Industry Growth Scenarios – Conservative, Likely & Optimistic

 2.6 Industry CxO’s Perspective

3. Market Overview

 3.1 Market Dynamics

  3.1.1 Drivers

  3.1.2 Restraints

  3.1.3 Opportunities

  3.1.4 Key Market Trends

 3.2 Industry PESTLE Analysis

 3.3 Key Industry Forces (Porter’s) Impacting Market Growth

 3.4 Industry Supply Chain Analysis

3.4.1 Raw Materials, Reagents & Technology Providers

3.4.2 RNAi Product Developers & Service Providers

3.4.3 Distributors & Research Service Partners

3.4.4 Pharmaceutical, Biotechnology & Research End Users

 3.5 Industry Life Cycle Assessment

4. Statistical Insights & Trends Reporting

4.1 RNAi Drug Development & Clinical Research Trends (2025)

4.1.1 Global RNAi Therapeutic Pipeline by Development Phase

4.1.2 Growth in siRNA and miRNA-Based Drug Candidates

4.1.3 RNAi Clinical Trial Activity by Therapeutic Area

4.1.4 Rare Disease and Oncology RNAi Research Trends

4.2 RNAi Research & Technology Adoption Trends (2025)

4.2.1 Academic and Commercial RNAi Research Activity

4.2.2 Functional Genomics and Gene Silencing Study Trends

4.2.3 siRNA, miRNA, and shRNA Utilization Analysis

4.2.4 RNAi Reagent and Consumables Demand Trends

4.3 Biopharmaceutical R&D Investment Trends (2025)

4.3.1 RNA-Based Therapeutics Funding and Investment Activity

4.3.2 Pharmaceutical and Biotechnology Company R&D Spending

4.3.3 Strategic Collaborations, Licensing, and Partnership Trends

4.3.4 Emerging RNA Therapeutics Company Activity Analysis

4.4 Regulatory & Commercialization Trends (2025)

4.4.1 Regulatory Approvals for RNAi Therapeutics

4.4.2 Global Clinical and Regulatory Framework Developments

4.4.3 Commercial Adoption Trends of Approved RNAi Drugs

4.4.4 Orphan Drug and Fast-Track Designation Trends

4.5 Innovation, Delivery Platform & Technology Trends (2025)

4.5.1 AI-Driven RNAi Drug Discovery Trends

4.5.2 Lipid Nanoparticle (LNP) and Delivery System Advancements

4.5.3 Next-Generation Gene Silencing Technology Developments

4.5.4 Precision Medicine and Biomarker-Based RNAi Therapy Trends

5. RNAi Technology Market Segmental Analysis & Forecast, By Product & Service, 2022–2035, Value (USD Billion)

5.1 Introduction

 5.2 Products

  5.2.1 Key Trends

  5.2.2 Market Size & Forecast, 2022–2035

  5.2.2 miRNA

  5.2.2 siRNA

  5.2.2 Others

 5.3 Service

  5.2.2 RNAi Services

6. RNAi Technology Market Segmental Analysis & Forecast, By Application, 2022–2035, Value (USD Billion)

    6.1 Introduction

 6.2 Drug Discovery & Development

  6.2.1 Key Trends

  6.2.2 Market Size & Forecast, 2022–2035

 6.3 Functional Genomics

 6.4 Others

7. RNAi Technology Market Segmental Analysis & Forecast, By End Use, 2022–2035, Value (USD Billion)

    7.1 Introduction

 7.2 Pharmaceutical & Biotechnology Companies

  7.2.1 Key Trends

  7.2.2 Market Size & Forecast, 2022–2035

 7.3 Academic & Research Institutes

 7.4 CROs & CMOs

8. RNAi Technology Market Segmental Analysis & Forecast by Region, 2022–2035, Value (USD Billion)

8.1 Introduction

8.2 North America

 8.2.1 Key Trends

 8.2.2 RNAi Technology Market Size & Forecast, By Product & Service, 2022–2035

 8.2.3 RNAi Technology Market Size & Forecast, By Application, 2022–2035

 8.2.4 RNAi Technology Market Size & Forecast, By End Use, 2022–2035

 8.2.5 RNAi Technology Market Size & Forecast, By Country, 2022–2035

  8.2.5.1 USA

  8.2.5.2 Canada

8.3 Europe

 8.3.1 Key Trends

 8.3.2 RNAi Technology Market Size & Forecast, By Product & Service, 2022–2035

 8.3.3 RNAi Technology Market Size & Forecast, By Application, 2022–2035

 8.3.4 RNAi Technology Market Size & Forecast, By End Use, 2022–2035

 8.3.5 RNAi Technology Market Size & Forecast, By Country, 2022–2035

  8.3.5.1 Germany

  8.3.5.2 UK

  8.3.5.3 France

  8.3.5.4 Italy

  8.3.5.5 Spain

  8.3.5.6 Russia

  8.3.5.7 Poland

  8.3.5.8 Rest of Europe

8.4 Asia-Pacific

 8.4.1 Key Trends

 8.4.2 RNAi Technology Market Size & Forecast, By Product & Service, 2022–2035

 8.4.3 RNAi Technology Market Size & Forecast, By Application, 2022–2035

 8.4.4 RNAi Technology Market Size & Forecast, By End Use, 2022–2035

 8.4.5 RNAi Technology Market Size & Forecast, By Country, 2022–2035

  8.4.5.1 China

  8.4.5.2 India

  8.4.5.3 Japan

  8.4.5.4 South Korea

  8.4.5.5 Australia

  8.4.5.6 ASEAN Countries

  8.4.5.7 Rest of Asia-Pacific

8.5 Latin America

 8.5.1 Key Trends

 8.5.2 RNAi Technology Market Size & Forecast, By Product & Service, 2022–2035

 8.5.3 RNAi Technology Market Size & Forecast, By Application, 2022–2035

 8.5.4 RNAi Technology Market Size & Forecast, By End Use, 2022–2035

 8.5.5 RNAi Technology Market Size & Forecast, By Country, 2022–2035

  8.5.5.1 Brazil

  8.5.5.2 Argentina

  8.5.5.3 Mexico

  8.5.5.4 Colombia

  8.5.5.5 Rest of Latin America

8.6 Middle East & Africa

 8.6.1 Key Trends

 8.6.2 RNAi Technology Market Size & Forecast, By Product & Service, 2022–2035

 8.6.3 RNAi Technology Market Size & Forecast, By Application, 2022–2035

 8.6.4 RNAi Technology Market Size & Forecast, By End Use, 2022–2035

 8.6.5 RNAi Technology Market Size & Forecast, By Country, 2022–2035

  8.6.5.1 UAE

  8.6.5.2 Saudi Arabia

  8.6.5.3 Qatar

  8.6.5.4 Egypt

  8.6.5.5 South Africa

  8.6.5.6 Rest of Middle East & Africa

9. Competitive Landscape

 9.1 Key Players' Positioning

 9.2 Competitive Developments

  9.2.1 Key Strategies Adopted (%), By Key Players, 2025

  9.2.2 Year-Wise Strategies & Development, 2022–2025

  9.2.3 Number of Strategies Adopted by Key Players, 2025

 9.3 Market Share Analysis, 2025

 9.4 Product/Service & Application Benchmarking

  9.4.1 Product/Service Specifications & Features by Key Players

  9.4.2 Product/Service Heatmap by Key Players

  9.4.3 Application Heatmap by Key Players

 9.5 Industry Start-Up & Innovation Landscape

9.6 Key Company Profiles

 9.6.1 Alnylam Pharmaceuticals Inc.

  9.6.1.1 Company Overview & Snapshot

  9.6.1.2 Product/Service Portfolio

  9.6.1.3 Key Company Financials

  9.6.1.4 SWOT Analysis

 9.6.2 Arrowhead Pharmaceuticals Inc.

 9.6.3 Ionis Pharmaceuticals Inc.

 9.6.4 Moderna Inc.

 9.6.5 Dicerna Pharmaceuticals Inc. (Novo Nordisk)

 9.6.6 Silence Therapeutics plc

 9.6.7 Arbutus Biopharma Corporation

 9.6.8 Sirnaomics Inc.

 9.6.9 Regulus Therapeutics Inc.

 9.6.10 Genevant Sciences

 9.6.11 Sarepta Therapeutics Inc.

 9.6.12 OliX Pharmaceuticals Inc.

 9.6.13 Benitec Biopharma Inc.

 9.6.14 Phio Pharmaceuticals Corp.

 9.6.15 RXi Pharmaceuticals Corporation

 9.6.16 Quark Pharmaceuticals Inc.

 9.6.17 Takeda Pharmaceutical Company Limited

 9.6.18 AstraZeneca plc

 9.6.19 Sanofi S.A.

 9.6.20 Eli Lilly and Company

10. Analyst Recommendations

 10.1 SNS Insider Opportunity Map

 10.2 Industry Low-Hanging Fruit Assessment

 10.3 Market Entry & Growth Strategy

 10.4 Analyst Viewpoint & Suggestions on Market Growth

11. Assumptions

12. Disclaimer

13. Appendix

 13.1 List of Tables

 13.2 List of Figures